Click on headlines below to download research

Executive interview - e-Therapeutics
Executive interview - e-Therapeutics | 09/08/2017

e-Therapeutics (ETX) is a UK-based drug discovery company that has developed a proprietary, computer-based discovery platform based on network biology.…

Strategic review complete: focus on deal-making
e-Therapeutics | 27/07/2017

New CEO Dr Ray Barlow, who joined e-Therapeutics (ETX) in April, has undertaken a business and strategic review, assisted by an independent industry-wide…

Right place, right time
e-Therapeutics | 05/05/2017

e-Therapeutics offers public market investors a unique opportunity to gain exposure to a proprietary, cutting-edge in silico drug discovery platform that…